Showing posts with label doxil.. Show all posts
Showing posts with label doxil.. Show all posts
Tuesday, July 20, 2010
Trabectedin (Yondelis) plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial — Ann Oncol (full free access)
add your opinions
doxil.
,
pegylated liposomal doxorubicin
,
trabectedin
,
Yondelis
Subscribe to:
Posts
(
Atom
)